This week, three interviews, and five guests. We have conversations with Ulrik Tirsted Zeuthen, CEO, and Katarina Cantell, founder/CSO of Adalyon; Nisit Khandelwal, co-founder/CEO, Cycuria Therapeutics; and Craig Ritchie, founder/CEO of Scottish Brain Sciences and Deborah O’Neil, CEO/CSO of NovaBiotics as well as chair of the Life Sciences board of Opportunity Northeast, which runs ONE BioHub, and BioAberdeen.

Times:

02:38 Adalyon

32:44 Cycuria Therapeutics

53:43 Scottish Brain Sciences/One BioHub

Cycuria Therapeutics

Cycuria Therapeutics is a preclinical oncology company based in Graz, Austria, which is developing first‑in‑class protein therapeutics for hard‑to‑treat blood cancers. Its  ...